APA (7th ed.) Citation

Ding, S., Chen, R., Wang, L., Zu, C., Zhou, X., Zhang, J., . . . Hu, Y. (2023). Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11540-8

Chicago Style (17th ed.) Citation

Ding, Shuyi, et al. "Cytokine Release Syndrome Was an Independent Risk Factor Associated with Hypoalbuminemia for Patients with Relapsed/refractory Hematological Malignancies After CAR-T Cell Therapy." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11540-8.

MLA (9th ed.) Citation

Ding, Shuyi, et al. "Cytokine Release Syndrome Was an Independent Risk Factor Associated with Hypoalbuminemia for Patients with Relapsed/refractory Hematological Malignancies After CAR-T Cell Therapy." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11540-8.